Organogenesis Holdings Inc. ORGO Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $37.03M+4,201% | $861K— | —— | $15.53M-83.5% | ||
| $15.27M+12.1% | $13.62M+30.4% | $10.45M+78.8% | $5.85M+1.1% | ||
| $13.3M+25.7% | $10.58M+17.6% | $9M+37.3% | $6.55M+69.6% | ||
| $9.5M— | —— | —— | $1.98M+106% | ||
| -$188K+83.5% | -$1.14M-385% | -$235K+94.8% | -$4.48M-219% | ||
| $115.8M+233% | $34.78M+728% | -$5.54M— | —— | ||
| $18.85M— | —— | $8.18M-13.1% | $9.41M-3.4% | ||
| -$528K— | —— | —— | —— | ||
| —— | —— | —— | —— | ||
| —— | -$1.06M-1,267% | $91K+26.4% | $72K+101% | ||
| $3.32M-2.4% | $3.4M-30.8% | $4.92M+0.7% | $4.88M-1.3% | ||
| $8.34M-0.1% | $8.35M+3.3% | $8.08M+10.7% | $7.3M+22.8% | ||
| —— | $14.21M-54.0% | $30.92M+24.4% | $24.86M-59.9% | ||
| $14.15M+41.1% | $10.03M-58.8% | $24.36M-28.1% | $33.9M+8.6% | ||
| -$14.15M-41.1% | -$10.03M+58.8% | -$24.36M+28.1% | -$33.9M-8.6% | ||
| —— | $25.48M— | $0— | $0— | ||
| $157K-87.4% | $1.25M— | $0-100% | $2.07M-5.8% | ||
| $1.17M+8.3% | $1.08M+123% | $485K— | —— | ||
| $1.89M+60.3% | $1.18M+253% | $333K-48.6% | $648K— | ||
| —— | $120.69M— | $0— | $0— | ||
| -$17.36M-163% | $27.64M+602% | -$5.51M— | —— | ||
| —— | —— | —— | —— | ||
| —— | $4.97M-8.6% | $5.44M+105% | $2.65M-54.6% | ||
| $5.35M-23.2% | $6.97M+128% | $3.05M+154% | $1.2M+97.9% | ||
| -$15.35M-87.0% | -$8.21M-24.8% | -$6.58M+31.8% | -$9.65M+20.1% | ||
| $3.32M-2.4% | $3.4M-30.8% | $4.92M+0.7% | $4.88M-1.3% | ||
| —— | $0+100% | -$559K— | $0— | ||
| $10.38M— | —— | —— | —— | ||
| $8.49M-39.6% | $14.07M+66.7% | $8.44M— | —— | ||
| —— | —— | —— | —— | ||
| $375K-4.8% | $394K-7.7% | $427K-1.6% | $434K+25.4% | ||
| $8.34M-0.1% | $8.35M+3.3% | $8.08M+10.7% | $7.3M+22.8% | ||
| $8.21M+109% | $3.94M— | —— | $1.78M-40.6% | ||
| $11.18M— | —— | —— | —— | ||
| $14.46M— | —— | —— | —— | ||
| $1.17M+8.3% | $1.08M+123% | $485K— | —— | ||
| —— | $120.69M— | $0— | $0— | ||
| $11.37M+532% | $1.8M— | $0— | $0— | ||
| —— | —— | $841K-56.4% | $1.93M— | ||
| —— | —— | —— | —— | ||
| $2.69M— | —— | —— | —— | ||
| —— | $67K— | $0— | $0— | ||
| —— | $0-100% | $3.45M— | $0— | ||
| $26.98M+428% | $5.11M-12.9% | $5.87M— | —— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Organogenesis Holdings Inc. generate?
- Organogenesis Holdings Inc. (ORGO) generated -$20.7M in operating cash flow over the trailing twelve months.
- What is Organogenesis Holdings Inc.'s free cash flow?
- After $13.7M of capital expenditures, Organogenesis Holdings Inc.'s free cash flow was -$34.5M over the trailing twelve months, down 67.6% year over year.
- Where does Organogenesis Holdings Inc.'s cash flow data come from?
- Every line is extracted from Organogenesis Holdings Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
